Sill H - Search Results

1

Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group.

Pleyer L, Döhner H, Dombret H, Seymour JF, Schuh AC, Beach CL, Swern AS, Burgstaller S, Stauder R, Girschikofsky M, Sill H, Schlick K, Thaler J, Halter B, Machherndl Spandl S, Zebisch A, Pichler A, Pfeilstöcker M, Autzinger EM, Lang A, Geissler K, Voskova D, Sperr WR, Hojas S, Rogulj IM, Andel J, Greil R. Pleyer L, et al. Among authors: sill h. Int J Mol Sci. 2017 Feb 15;18(2):415. doi: 10.3390/ijms18020415. Int J Mol Sci. 2017. PMID: 28212292 Free PMC article.

2

Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: long-term results of a multicenter phase-II study. Austrian Biological Response Modifier (BRM) Study Group.

Thaler J, Gastl G, Fluckinger T, Niederwieser D, Huber H, Seewann H, Sill H, Lang A, Falk M, Duba C, Utermann G, Kühr T, Aulitzky W, Huber C. Thaler J, et al. Among authors: sill h. Ann Hematol. 1996 Jun;72(6):349-55. doi: 10.1007/s002770050185. Ann Hematol. 1996. PMID: 8767103 Clinical Trial.

3

Interferon-alpha-2C and LD ara-C for the treatment of patients with CML: results of the Austrian multi-center phase II study.

Thaler J, Hilbe W, Apfelbeck U, Linkesch W, Sill H, Seewann H, Pont J, Bernhart M, Stöger M, Niessner H, Abbrederis K, Geissler D, Hausmaninger H, Lin W, Ludwig H, Lang A, Duba C, Fluckinger T, Greil R, Grünewald K, Konwalinka G, Niederwieser D, Fridrik M. Thaler J, et al. Among authors: sill h. Leuk Res. 1997 Jan;21(1):75-80. doi: 10.1016/s0145-2126(96)00084-7. Leuk Res. 1997. PMID: 9029189 Clinical Trial.

4

Long-lasting haematological remission despite persistence of the Philadelphia-positive clone in an untreated chronic myeloid leukaemia patient.

Hilbe W, Sill H, Eisterer W, Lin F, Bechter O, Grünewald K, Thaler J. Hilbe W, et al. Among authors: sill h. Acta Haematol. 1998;100(2):101-3. doi: 10.1159/000040877. Acta Haematol. 1998. PMID: 9792944 Review. No abstract available.

5

Therapy-related leukemia cutis: case study of an aggressive disorder.

Zebisch A, Cerroni L, Beham-Schmid C, Sill H. Zebisch A, et al. Among authors: sill h. Ann Hematol. 2003 Nov;82(11):705-7. doi: 10.1007/s00277-003-0717-y. Epub 2003 Aug 14. Ann Hematol. 2003. PMID: 12920571

6

High expression of the sister-chromatid separation regulator and proto-oncogene hSecurin occurs in a subset of myeloid leukaemias but is not implicated in the pathogenesis of aneuploidy.

Auner HW, Zebisch A, Schimek MG, Bodner C, Hiden K, Linkesch W, Haas OA, Beham-Schmid C, Sill H. Auner HW, et al. Among authors: sill h. Leukemia. 2004 Feb;18(2):303-8. doi: 10.1038/sj.leu.2403235. Leukemia. 2004. PMID: 14671639

7

RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: breakpoint cluster region and clinical implications.

Schmidt HH, Strehl S, Thaler D, Strunk D, Sill H, Linkesch W, Jäger U, Sperr W, Greinix HT, König M, Emberger W, Haas OA. Schmidt HH, et al. Among authors: sill h. Leukemia. 2004 Jun;18(6):1115-21. doi: 10.1038/sj.leu.2403353. Leukemia. 2004. PMID: 15085163

8

Bedside RNA stabilizing kit systems for gene expression analysis of acute leukemias: influence of non-neoplastic white blood cells.

Zebisch A, Linkesch W, Sill H. Zebisch A, et al. Among authors: sill h. Leukemia. 2005 Jan;19(1):136-7. doi: 10.1038/sj.leu.2403581. Leukemia. 2005. PMID: 15510197 No abstract available.

9

A functional single-nucleotide polymorphism of the G-CSF receptor gene predisposes individuals to high-risk myelodysplastic syndrome.

Wölfler A, Erkeland SJ, Bodner C, Valkhof M, Renner W, Leitner C, Olipitz W, Pfeilstöcker M, Tinchon C, Emberger W, Linkesch W, Touw IP, Sill H. Wölfler A, et al. Among authors: sill h. Blood. 2005 May 1;105(9):3731-6. doi: 10.1182/blood-2004-06-2094. Epub 2005 Jan 11. Blood. 2005. PMID: 15644419 Free article.

10

Bedside RNA stabilizing kit systems for gene expression analysis of acute leukemias: influence of non-neoplastic white blood cells.

Zebisch A, Linkesch W, Sill H. Zebisch A, et al. Among authors: sill h. Leukemia. 2005 Apr;19(4):685. doi: 10.1038/sj.leu.2403713. Leukemia. 2005. PMID: 15861178 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

193 results

Search Page